BioLife Solutions, Inc. 09062W204 US09062W2044 07/21/2023 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 7148887 0 FOR 7148887 FOR EQRx, Inc. 26886C107 US26886C1071 11/08/2023 To approve, on a non-binding, advisory basis, the compensation that will or may be payable to EQRX's named executive officers that is based on or otherwise relates to the transactions contemplated by the merger agreement. SECTION 14A SAY-ON-PAY VOTES 39527669 0 FOR 39527669 FOR Standard BioTools Inc. 34385P108 US34385P1084 01/04/2024 Standard BioTools Advisory Compensation Proposal. To approve, on a non-binding, advisory basis, the compensation that may become payable to Standard BioTools' named executive officers and to SomaLogic's Chief Executive Officer that is based on or otherwise relates to the Merger, as disclosed in "The Merger - Interests of Standard BioTools Directors and Executive Officers in the Merger - Quantification of Potential Payments to Standard BioTools Named Executive Officers and SomaLogic's Chief Executive Officer in Connection with the Merger" beginning on page 127 of the accompanying joint proxy statement/prospectus (the "Standard BioTools Advisory Compensation Proposal"); SECTION 14A SAY-ON-PAY VOTES 1283368 0 FOR 1283368 FOR Syndax Pharmaceuticals, Inc. 87164F105 US87164F1057 05/15/2024 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2024 proxy statement. SECTION 14A SAY-ON-PAY VOTES 150000 0 FOR 150000 FOR Alnylam Pharmaceuticals, Inc. 02043Q107 US02043Q1076 05/16/2024 To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. SECTION 14A SAY-ON-PAY VOTES 121560 0 FOR 121560 FOR Illumina, Inc. 452327109 US4523271090 05/16/2024 To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES 28631 0 FOR 28631 FOR Denali Therapeutics Inc. 24823R105 US24823R1059 05/31/2024 Advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES 944745 0 FOR 944745 FOR Relay Therapeutics, Inc. 75943R102 US75943R1023 06/03/2024 To consider and act upon an advisory vote on the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES 7387943 0 FOR 7387943 FOR Beam Therapeutics Inc. 07373V105 US07373V1052 06/05/2024 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 199324 0 FOR 199324 FOR Sarepta Therapeutics, Inc. 803607100 US8036071004 06/06/2024 advisory vote to approve, on a non-binding basis, name executive officer compensation SECTION 14A SAY-ON-PAY VOTES 298109 0 FOR 298109 FOR Verve Therapeutics, Inc. 92539P101 US92539P1012 06/06/2024 Approval, on an advisory basis, of the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 3059094 0 FOR 3059094 FOR Verve Therapeutics, Inc. 92539P101 US92539P1012 06/06/2024 Approval, on an advisory basis, of the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 3059094 0 ONE YEAR 3059094 FOR Codexis, Inc. 192005106 US1920051067 06/11/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 2000000 0 FOR 2000000 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 191437 0 ONE YEAR 191437 FOR Blueprint Medicines Corporation 09627Y109 US09627Y1091 06/12/2024 Approval of a non-binding advisory vote on the compensation paid to our named executive officers. SECTION 14A SAY-ON-PAY VOTES 191437 0 FOR 191437 FOR Intellia Therapeutics, Inc. 45826J105 US45826J1051 06/12/2024 Approve, on a non-binding advisory basis, the compensation of the named executive officers. SECTION 14A SAY-ON-PAY VOTES 1875000 0 FOR 1875000 FOR Veracyte, Inc. 92337F107 US92337F1075 06/12/2024 The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement. SECTION 14A SAY-ON-PAY VOTES 390130 0 FOR 390130 FOR AbCellera Biologics Inc. 00288U106 CA00288U1066 06/13/2024 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay; SECTION 14A SAY-ON-PAY VOTES 814461 0 FOR 814461 FOR Avidity Biosciences, Inc. 05370A108 US05370A1088 06/13/2024 To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in the related proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and SECTION 14A SAY-ON-PAY VOTES 1157124 0 FOR 1157124 FOR Exact Sciences Corporation 30063P105 US30063P1057 06/13/2024 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES 348000 0 FOR 348000 FOR Pliant Therapeutics, Inc. 729139105 US7291391057 06/13/2024 To approve, by non-binding advisory vote, the resolution approving named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES 1000000 0 AGAINST 1000000 AGAINST Neurogene, Inc. 64135M105 US64135M1053 06/14/2024 To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES 137615 0 FOR 137615 FOR Revolution Medicines, Inc. 76155X100 US76155X1000 06/20/2024 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"). SECTION 14A SAY-ON-PAY VOTES 5616072 0 FOR 5616072 FOR Kronos Bio, Inc. 50107A104 US50107A1043 06/25/2024 Advisory approval of the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement in accordance with SEC rules. SECTION 14A SAY-ON-PAY VOTES 123839 0 FOR 123839 FOR Standard BioTools Inc. 34385P108 US34385P1084 06/27/2024 To approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES 61907605 0 FOR 61907605 FOR